Free Trial

MarketBeat Instant News Alerts

National Beverage logo with Consumer Staples background

UBS Group Lowers National Beverage (NASDAQ:FIZZ) Price Target to $39.00

UBS Group reduced their price objective on National Beverage from $40.00 to $39.00 and set a "sell" rating for the company in a research note on Monday.

NASDAQ:FIZZ
Read UBS Group Lowers National Beverage (NASDAQ:FIZZ) Price Target to $39.00
Portillo's logo with Retail/Wholesale background

Portillo's (NASDAQ:PTLO) Price Target Cut to $7.50 by Analysts at UBS Group

UBS Group dropped their target price on Portillo's from $9.00 to $7.50 and set a "neutral" rating on the stock in a research report on Monday.

NASDAQ:PTLO
Read Portillo's (NASDAQ:PTLO) Price Target Cut to $7.50 by Analysts at UBS Group
RealReal logo with Consumer Discretionary background

B. Riley Raises RealReal (NASDAQ:REAL) Price Target to $12.00

B. Riley increased their price objective on shares of RealReal from $9.00 to $12.00 and gave the company a "buy" rating in a research note on Monday.

NASDAQ:REAL
Read B. Riley Raises RealReal (NASDAQ:REAL) Price Target to $12.00
Remitly Global logo with Business Services background

JMP Securities Lowers Remitly Global (NASDAQ:RELY) Price Target to $23.00

JMP Securities reduced their target price on Remitly Global from $32.00 to $23.00 and set a "market outperform" rating on the stock in a report on Monday.

NASDAQ:RELY
Read JMP Securities Lowers Remitly Global (NASDAQ:RELY) Price Target to $23.00
RF Industries logo with Computer and Technology background

RF Industries (NASDAQ:RFIL) Given New $9.25 Price Target at B. Riley

B. Riley boosted their price objective on RF Industries from $6.25 to $9.25 and gave the stock a "buy" rating in a research report on Monday.

NASDAQ:RFIL
Read RF Industries (NASDAQ:RFIL) Given New $9.25 Price Target at B. Riley
Unicycive Therapeutics logo with Medical background

Unicycive Therapeutics (NASDAQ:UNCY) Price Target Raised to $21.00 at Benchmark

Benchmark increased their price target on shares of Unicycive Therapeutics from $3.00 to $21.00 and gave the company a "speculative buy" rating in a research report on Monday.

NASDAQ:UNCY
Read Unicycive Therapeutics (NASDAQ:UNCY) Price Target Raised to $21.00 at Benchmark

Trending News

All MarketBeat Instant News Alerts

Maze Therapeutics logo with Medical background

Guggenheim Forecasts Strong Price Appreciation for Maze Therapeutics (NASDAQ:MAZE) Stock

NASDAQ:MAZE
Read Guggenheim Forecasts Strong Price Appreciation for Maze Therapeutics (NASDAQ:MAZE) Stock
Auto Trader Group logo with Retail/Wholesale background

Auto Trader Group (OTCMKTS:ATDRY) Short Interest Update

OTCMKTS:ATDRY
Read Auto Trader Group (OTCMKTS:ATDRY) Short Interest Update
Endeavour Mining logo with Basic Materials background

Endeavour Mining (LON:EDV) Reaches New 52-Week High - Here's What Happened

LON:EDV
Read Endeavour Mining (LON:EDV) Reaches New 52-Week High - Here's What Happened
ImmuPharma logo with Medical background

ImmuPharma (LON:IMM) Shares Up 26.5% - Time to Buy?

LON:IMM
Read ImmuPharma (LON:IMM) Shares Up 26.5% - Time to Buy?
TAT Technologies logo with Aerospace background

TAT Technologies Ltd. (NASDAQ:TATT) Short Interest Update

NASDAQ:TATT
Read TAT Technologies Ltd. (NASDAQ:TATT) Short Interest Update
Interface logo with Consumer Discretionary background

Interface, Inc. (NASDAQ:TILE) Short Interest Update

NASDAQ:TILE
Read Interface, Inc. (NASDAQ:TILE) Short Interest Update
Towne Bank logo with Finance background

Towne Bank (NASDAQ:TOWN) Short Interest Update

NASDAQ:TOWN
Read Towne Bank (NASDAQ:TOWN) Short Interest Update
Alaska Air Group logo with Transportation background

Alaska Air Group (NYSE:ALK) Updates Q3 2025 Earnings Guidance

NYSE:ALK
Read Alaska Air Group (NYSE:ALK) Updates Q3 2025 Earnings Guidance
Fair Isaac logo with Computer and Technology background

UBS Group Boosts Fair Isaac (NYSE:FICO) Price Target to $1,640.00

NYSE:FICO
Read UBS Group Boosts Fair Isaac (NYSE:FICO) Price Target to $1,640.00
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics' (SRPT) Buy Rating Reiterated at Guggenheim

NASDAQ:SRPT
Read Sarepta Therapeutics' (SRPT) Buy Rating Reiterated at Guggenheim
Comfort Systems USA logo with Construction background

UBS Group Issues Positive Forecast for Comfort Systems USA (NYSE:FIX) Stock Price

NYSE:FIX
Read UBS Group Issues Positive Forecast for Comfort Systems USA (NYSE:FIX) Stock Price
Occidental Petroleum logo with Energy background

Occidental Petroleum (NYSE:OXY) Price Target Raised to $46.00

NYSE:OXY
Read Occidental Petroleum (NYSE:OXY) Price Target Raised to $46.00
Antero Resources logo with Energy background

UBS Group Issues Pessimistic Forecast for Antero Resources (NYSE:AR) Stock Price

NYSE:AR
Read UBS Group Issues Pessimistic Forecast for Antero Resources (NYSE:AR) Stock Price
NextDecade logo with Energy background

NextDecade (NASDAQ:NEXT) Earns "Hold" Rating from TD Cowen

NASDAQ:NEXT
Read NextDecade (NASDAQ:NEXT) Earns "Hold" Rating from TD Cowen
Simon Property Group logo with Finance background

Simon Property Group's (SPG) In-Line Rating Reaffirmed at Evercore ISI

NYSE:SPG
Read Simon Property Group's (SPG) In-Line Rating Reaffirmed at Evercore ISI
Under Armour logo with Consumer Discretionary background

Rothschild & Co Redburn Reaffirms Neutral Rating for Under Armour (NYSE:UAA)

NYSE:UAA
Read Rothschild & Co Redburn Reaffirms Neutral Rating for Under Armour (NYSE:UAA)
Bullish logo with Computer and Technology background

Keefe, Bruyette & Woods Begins Coverage on Bullish (NYSE:BLSH)

NYSE:BLSH
Read Keefe, Bruyette & Woods Begins Coverage on Bullish (NYSE:BLSH)
Scholar Rock logo with Medical background

Leerink Partners Initiates Coverage on Scholar Rock (NASDAQ:SRRK)

NASDAQ:SRRK
Read Leerink Partners Initiates Coverage on Scholar Rock (NASDAQ:SRRK)
West Pharmaceutical Services logo with Medical background

West Pharmaceutical Services (NYSE:WST) Now Covered by Analysts at Rothschild & Co Redburn

NYSE:WST
Read West Pharmaceutical Services (NYSE:WST) Now Covered by Analysts at Rothschild & Co Redburn
argenex logo with Medical background

argenex (NASDAQ:ARGX) Stock Price Expected to Rise, Truist Financial Analyst Says

NASDAQ:ARGX
Read argenex (NASDAQ:ARGX) Stock Price Expected to Rise, Truist Financial Analyst Says
Bitfarms logo with Business Services background

Compass Point Initiates Coverage on Bitfarms (NASDAQ:BITF)

NASDAQ:BITF
Read Compass Point Initiates Coverage on Bitfarms (NASDAQ:BITF)
Canaan logo with Finance background

Canaan (NASDAQ:CAN) Now Covered by Analysts at Compass Point

NASDAQ:CAN
Read Canaan (NASDAQ:CAN) Now Covered by Analysts at Compass Point
Cipher Mining logo with Business Services background

Cipher Mining (NASDAQ:CIFR) Coverage Initiated by Analysts at Compass Point

NASDAQ:CIFR
Read Cipher Mining (NASDAQ:CIFR) Coverage Initiated by Analysts at Compass Point
Core Scientific logo with Finance background

Compass Point Initiates Coverage on Core Scientific (NASDAQ:CORZ)

NASDAQ:CORZ
Read Compass Point Initiates Coverage on Core Scientific (NASDAQ:CORZ)